Showing results (251-260 of 817) with videos related to
Sort By:
Pageof 82
Thescientificworldjournal|May 27, 2009
Low mortality and key aspects of delivery of care for end-stage renal disease in ItalyAlexander Lauder, Arrigo Schieppati, Ferruccio Conte, et al.Journal of Hepatology|April 13, 2013
Monogenic diseases that can be cured by liver transplantationStefano Fagiuoli, Erica Daina, Lorenzo D'Antiga, et al.Nephron|May 21, 2016
Another Piece of the Puzzle of Podocyte B7-1 Expression: Lupus NephritisRubina Novelli, Elena Gagliardini, Barbara Ruggiero, et al.Seminars in Nephrology|November 10, 2023
HUS and TTP: traversing the disease and the age spectrumRoberta Donadelli, Aditi Sinha, Arvind Bagga, et al.Current Diabetes Reviews|March 29, 2011
Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectivesManuela Abbate, Paolo Cravedi, Ilian Iliev, et al.Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?Paolo Cravedi, Varusca Brusegan, Piero Ruggenenti, et al.Kidney International|August 8, 2002
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantationDario Cattaneo, Norberto Perico, Flavio Gaspari, et al.Pediatric Nephrology (Berlin, Germany)|October 6, 2016
Achieving remission of proteinuria in childhood CKDPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.Personalized Medicine|May 26, 2018
Pharmacogenetics and pharmacogenomics of immunosuppressive agents: perspective for individualized therapyDario Cattaneo, Anna Tankiewicz, Simona Merlini, et al.American Journal of Physiology. Renal Physiology|December 25, 2015
Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?Rubina Novelli, Elena Gagliardini, Barbara Ruggiero, et al.Pageof 82